Fortrea Holdings (FTRE) Common Equity (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Common Equity came in at $524.2 million in Q2 2026, down 11.03% on a YoY basis from $589.2 million in Q2 2025, and little changed quarter-over-quarter from $525.9 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Common Equity (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Common Equity for 5 consecutive years, with $524.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Common Equity fell 11.03% year-over-year to $524.2 million; the trailing twelve-month figure through Jun 2026 stood at $524.2 million (down 11.03% YoY), and the FY2025 full-year result was $563.5 million, down 58.64% from the prior year.
- Common Equity steadied at $524.2 million in Q2 2026 per FTRE's latest filing, from $525.9 million in the prior quarter.
- Across five years, Common Equity topped out at $3.4 billion in Q1 2023 and bottomed at $524.2 million in Q2 2026.
- Historically, Common Equity has averaged $1.5 billion across 5 years, with a median of $1.5 billion in 2024.
- The sharpest annual moves came in 2024 and 2025: Common Equity fell 10.47% in 2024, then slumped 61.63% in 2025.
- Over 5 years, Common Equity stood at $3.3 billion in 2022, then tumbled by 48.68% to $1.7 billion in 2023, then dropped by 20.52% to $1.4 billion in 2024, then tumbled by 58.64% to $563.5 million in 2025, then declined by 6.97% to $524.2 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $524.2 million, $525.9 million, and $563.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.69 Bn | 40.61 Bn | 1.44 Bn | 6.30 Bn |
| 2 | Medpace Holdings | 16.49 Bn | 15.99 Bn | 201.64 Mn | 433.86 Mn |
| 3 | Charles River Laboratories International | 13.08 Bn | 12.89 Bn | 452.07 Mn | 2.85 Bn |
| 4 | Icon | 12.93 Bn | 12.00 Bn | 479.29 Mn | 9.38 Bn |
| 5 | Fortrea Holdings | 1.61 Bn | 1.44 Bn | 139.20 Mn | 524.20 Mn |
| 6 | Evotec SE | 625.08 Mn | 199.20 Mn | - | 773.64 Mn |
| 7 | Ginkgo Bioworks Holdings | 418.52 Mn | 333.98 Mn | 18.44 Mn | 420.28 Mn |
| 8 | Champions Oncology | 72.88 Mn | 72.88 Mn | 7.03 Mn | 4.07 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 8.57 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | -2.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 524.20 Mn |
| Mar 31, 2026 | 525.90 Mn |
| Dec 31, 2025 | 563.50 Mn |
| Sep 30, 2025 | 580.80 Mn |
| Jun 30, 2025 | 589.20 Mn |
| Mar 31, 2025 | 858.80 Mn |
| Dec 31, 2024 | 1.36 Bn |
| Sep 30, 2024 | 1.51 Bn |
| Jun 30, 2024 | 1.46 Bn |
| Mar 31, 2024 | 1.59 Bn |
| Dec 31, 2023 | 1.71 Bn |
| Sep 30, 2023 | 1.69 Bn |
| Jun 30, 2023 | 1.75 Bn |
| Mar 31, 2023 | 3.40 Bn |
| Dec 31, 2022 | 3.34 Bn |
| Jun 30, 2022 | 3.30 Bn |